ALT · Altimmune, Inc. · Documents
$2.12
-0.05 (-2.30%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$412.38M
Shares
194.52M
Volume · Oct 23
2.6M
Avg daily vol (3M)
4.32M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| S-3 | — | 2020-12-31 | — | |
| 8-K | — | 2020-12-23 | — | |
| 8-K | — | 2020-11-09 | — | |
| 10-Q | — | 2020-11-09 | 2020-09-30 | |
| 8-K | — | 2020-09-25 | 2020-09-24 | |
| DEF 14A | — | 2020-08-21 | 2020-09-24 | |
| 10-Q | — | 2020-08-11 | 2020-06-30 | |
| 8-K | — | 2020-08-11 | — | |
| 8-K/A | — | 2020-07-16 | 2020-05-11 | |
| 8-K | — | 2020-07-16 | 2020-07-13 | |
| 8-K | — | 2020-07-13 | — | |
| 8-K | — | 2020-06-01 | — | |
| 10-Q | — | 2020-05-13 | 2020-03-31 | |
| 8-K | — | 2020-05-13 | — | |
| 8-K | — | 2020-05-12 | 2020-05-11 | |
| 8-K | — | 2020-04-08 | 2020-04-02 | |
| 8-K | — | 2020-03-27 | — | |
| 8-K | — | 2020-03-27 | — | |
| 10-K | — | 2020-03-27 | 2019-12-31 |
Showing 101–119 of 119 filings
Key facts
CIK
1326190
CUSIP
02155H200
13F (30d)
23 filings
23 filers
Visit website
Investor relations